Search
Advanced Search
Share this Article info
  • Facebook StumbleUpon Connotea CiteULike Bibliography

Open Access

Correspondence

Copper Deficiency, Lead, and Paraoxonase

Leslie M. Klevay

University of North Dakota, School of Medicine and Health Sciences, Grand Forks, North Dakota, E-mail:leslie_klevay@und.nodak.edu

Citation: Klevay LM 2007. Copper Deficiency, Lead, and Paraoxonase. Environ Health Perspect 115:A341-A342. http://dx.doi.org/10.1289/ehp.10151

Online: 1 July 2007

The author declares he has no competing financial interests.

Li et al. (2006) measured paraoxonase 1 (PON1) in workers and found an inverse association between lead exposure and enzyme activity. This observation compliments some epidemiology and related experiments with animals, because low paraoxonase activity is associated with diabetes mellitus, familial hypercholesterolemia, ischemic heart disease, and metabolic syndrome (Klevay 2004). Paraoxonase, although studied most extensively because of its ability to detoxify organophosphate insecticides (James 2006;van Himbergen et al. 2006), has drawn increasing attention because it hydrolyzes homocysteine thiolactone, a vascular toxin that inhibits copper enzymes (Klevay 2006).

Lead intoxication has many manifestations (Fischbein 1998), lesser-known of which is induction of copper deficiency (Klauder and Petering 1977). Rats deficient in copper have an approximately 28% decrease in paraoxonase activity (Klevay 2004). These observations are consonant with the decrease in superoxide dismutase (SOD) associated with occupational exposure to lead (Ito et al. 1985) because this enzyme also depends on adequate copper nutriture for activity (Linder and Goode 1980;Owen 1981). Thus, SOD is an index of copper nutriture in humans (Uauy et al. 1985).

Li et al. (2006) stated that “the mechanism by which heavy metals inhibit serum PON1 activity is still not clear.” It seems likely that lead interferes with copper utilization in the workers, leading to low copper nutritional status (Li et al. 2006). Low copper status has been related to a large variety of adverse cardiovascular phenomena in both animals and people; in this context, the most important are hypercholesterolemia, hypertension, and impaired oxidative defense (Klevay 2000, 2002).

Are there unpublished copper data on the workers, or can they be reexamined to test this copper hypothesis? Plasma copper and ceruloplasmin are not likely to be useful because they are increased by inflammation (Pepys 1996) and may be falsely high. Extracellular SOD may be helpful because it is sensitive to low copper status (Johnson et al. 2005), and low values have been associated with atherosclerosis in humans (Landmesser et al. 2000;Wang et al. 1998).

References Top

  1. Fischbein A 1998. Occupational and environmental exposure to lead In: Rom WN. , editor. Environmental & Occupational Medicine. Philadelphia: Lippincott-Raven. pp. 973–996.
  2. Ito Y, Niiya Y, Kurita H, Shima S, Sarai S. 1985. Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead Int Arch Occup Environ Health 56:119–127.4055067 Find this article online
  3. James RW. 2006. A long and winding road: defining the biological role and clinical importance of paraoxonases Clin Chem Lab Med 44:1052–1059.16958594 Find this article online
  4. Johnson WT, Johnson LA, Lukaski HC. 2005. Serum superoxide dismutase 3 (extracellular superoxide dismutase) activity is a sensitive indicator of Cu status in rats J Nutr Biochem 16:682–692.16081273 Find this article online
  5. Klauder DS, Petering HG. 1977. Anemia of lead intoxication: a role for copper J Nutr 107:1779–1785.903822 Find this article online
  6. Klevay LM 2000. Trace element and mineral nutrition in disease: ischemic heart disease In: Bogden JD, Klevay LM. , editors. Clinical Nutrition of the Essential Trace Elements and Minerals: The Guide for Health Professionals. Totowa, NJ: Humana Press Inc. pp. 251–271.
  7. Klevay LM 2002. Advances in cardiovascular-copper research In: Schrauzer GN. , editor. First International Bio-minerals Symposium: Trace Elements in Nutrition, Health and Disease. Montreal, Quebec, Canada: Institut Rosell. pp. 64–71.
  8. Klevay LM. 2004. Ischemic heart disease as deficiency disease Cell Mol Biol (Noisy-le-grand) 50:877–884.15704251 Find this article online
  9. Klevay LM. 2006. How dietary deficiency, genes and a toxin can cooperate to produce arteriosclerosis and ischemic heart disease Cell Mol Biol (Noisy-le-grand) 52:11–15.17543200 Find this article online
  10. Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B. 2000. Vascular extracellular super-oxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation Circulation 101:2264–2270.10811593 Find this article online
  11. Li WF, Pan MH, Chung MC, Ho CK, Chuang HY. 2006. Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes Environ Health Perspect 114:1233–1236.10.1289/ehp.916316882531 Find this article online
  12. Linder MC, Goode CA 1980. Biochemistry of Copper. New York: Plenum Press.
  13. Owen CA, Jr 1981. Copper Deficiency and Toxicity. Park Ridge, N.J: Noyes Publication.
  14. Pepys MB 1996. The acute phase response and C-reactive protein In: Weatherall DJ, Ledingham JG, Warrell DA. , editors. Oxford Textbook of Medicine. Oxford, UK: Oxford University Press. pp. 1527–1533.
  15. Uauy R, Castillo-Duran C, Fisberg M, Fernandez N, Valenzuela A. 1985. Red cell superoxide dismutase activity as an index of human copper nutrition J Nutr 115:1650–1655.3934352 Find this article online
  16. van Himbergen TM, van Tits LJ, Roest M, Stalenhoef AF. 2006. The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine Neth J Med 64:34–38.16517986 Find this article online
  17. Wang XL, Adachi T, Sim AS, Wilcken DE. 1998. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease Arterioscler Thromb Vasc Biol 18:1915–1921.9848884 Find this article online
Post Your Note (For Public Viewing)
Compose Your Note
 
Declare any competing interests.
Add a note to this text.
Please follow our guidelines for notes and comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
  • Remarks that could be interpreted as allegations of misconduct
  • Unsupported assertions or statements
  • Inflammatory or insulting language
Add a note to this text.
You must be logged in to add a note to an article. You may log in by clicking here or cancel this note.
Add a note to this text.
You cannot annotate this area of the document. Close
Add a note to this text.
You cannot create an annotation that spans different sections of the document; please adjust your selection.
Close
Rate This Article
Please follow our guidelines for rating and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
  1. Remarks that could be interpreted as allegations of misconduct
  2. Unsupported assertions or statements
  3. Inflammatory or insulting language
Compose Your Annotation
 
Declare any competing interests.